相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Top-Down Mass Spectrometric Approach for the Full Characterization of Insulin-Cisplatin Adducts
Estefania Moreno-Gordaliza et al.
ANALYTICAL CHEMISTRY (2009)
Organometallic compounds in oncology: implications of novel organotins as antitumor agents
Angela Alama et al.
DRUG DISCOVERY TODAY (2009)
New-generation platinum agents for solid tumors
Neel Shah et al.
FUTURE ONCOLOGY (2009)
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Stefania Nobili et al.
MEDICINAL RESEARCH REVIEWS (2009)
Identification and characterization of metallodrug binding proteins by (metallo)proteomics
Xuesong Sun et al.
METALLOMICS (2009)
Inhibition of transcription by platinum antitumor compounds
Ryan C. Todd et al.
METALLOMICS (2009)
Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration
R. Ramirez-Camacho et al.
ACTA OTO-LARYNGOLOGICA (2008)
Heteroatom(isotope)-tagged proteomics via ICP-MS: screening and quantification of proteins and their post-translational modifications
Alfredo Sanz-Medel
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
A study of oxaliplatin-nucleobase interactions using ion trap electrospray mass spectrometry
Samantha L. Kerr et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Characterisation of Cisplatin Binding Sites in Human Serum Proteins Using Hyphenated Multidimensional Liquid Chromatography and ESI Tandem Mass Spectrometry
Joanna Will et al.
CHEMMEDCHEM (2008)
Antitumour metal compounds: more than theme and variations
Michael A. Jakupec et al.
DALTON TRANSACTIONS (2008)
High Resolution Mass Spectrometry for Studying the Interactions of Cisplatin with Oligonucleotides
Alexander E. Egger et al.
INORGANIC CHEMISTRY (2008)
Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach
Christian G. Hartinger et al.
INORGANIC CHEMISTRY (2008)
Atomic (HPLC-ICP-MS) and molecular mass spectrometry (ESI-Q-TOF) to study cis-platin interactions with serum proteins
Diego Esteban-Fernandez et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2008)
Peculiar mechanistic and structural features of the carboplatin-cytochrome c system revealed by ESI-MS analysis
Chiara Gabbiani et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry
Joanna Will et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
Elemental mass spectrometry for quantitative proteomics
Alfredo Sanz-Medel et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster
Daniel Garcia Sar et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Reaction of Zn7Metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes:: trans-PtII complexes retain their N-donor ligands
Markus Knipp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents
Silvia Mandel et al.
PROGRESS IN NEUROBIOLOGY (2007)
Development of a liquid Chromatography-Electrospray ionization tandem mass spectrometry method for detecting Oxaliplatin-DNA intrastrand cross-links in biological samples
Rachel C. Le Pla et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Trends in sample preparation for classical and second generation proteomics
Benito Canas et al.
JOURNAL OF CHROMATOGRAPHY A (2007)
Speciation analysis of platinum antitumoral drugs in impacted tissues
D. Esteban-Fernandez et al.
TALANTA (2007)
Proteomic analysis of cisplatin-induced cochlear damage: Methods and early changes in protein expression
Donald E. Coling et al.
HEARING RESEARCH (2007)
A study of the interactions between carboplatin and blood plasma proteins using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry
Ruimin Xie et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme
Angela Casini et al.
CHEMICAL COMMUNICATIONS (2007)
Platination of superoxide dismutase with cisplatin: tracking the ammonia ligands using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS)
Stefan K. Weidt et al.
CHEMICAL COMMUNICATIONS (2007)
Mass spectrometric analysis of ubiquitin-platinum interactions of leading anticancer drugs: MALDI versus ESI
Christian G. Hartinger et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2007)
SEC-ICP-MS and ESI-MS as tools to study the interaction between cisplatin and cytosolic biomolecules
D. Esteban-Fernandez et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2007)
Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH2-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis
Adrian M. Ramos et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Identification of degradation products from aqueous carboplatin injection samples by electrospray mass spectrometry
K Vivekanandan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Exploring metallodrug-protein interactions by ESI mass spectrometry: The reaction of anticancer platinum drugs with horse heart cytochrome c
Angela Casini et al.
CHEMMEDCHEM (2006)
Role of copper transporters in the uptake and efflux of platinum containing drugs
R Safaei
CANCER LETTERS (2006)
Cisplatin-induced apoptosis in cultures of human Schwann cells
K Jirsova et al.
NEUROSCIENCE LETTERS (2006)
Top-down characterization of proteins and drug-protein complexes using nanoelectrospray tandem mass spectrometry
R Mandal et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Structural investigation of cisplatin-protein interactions: Selective platination of His19 in a cuprozinc superoxide dismutase
V Calderone et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Speciation studies of cis-platin adducts with DNA nucleotides via elemental specific detection (P and Pt) using liquid chromatography-inductively coupled plasma-mass spectrometry and structural characterization by electrospray mass spectrometry
Daniel Garcia Sar et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2006)
Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology
Andrei R. Timerbaev et al.
CHEMICAL REVIEWS (2006)
Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA
EL Meczes et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Characterization of intact hemoglobin and oxaliplatin interaction by nanoelectrospray ionization tandem mass spectrometry
J Peng et al.
CLINICAL CHEMISTRY (2005)
A mass spectrometric and molecular modelling study of cisplatin binding to transferrin
I Khalaila et al.
CHEMBIOCHEM (2005)
Determination of binding sites in carboplatin-bound cytochrome c using electrospray ionization mass spectrometry and tandem mass spectrometry
GS Yang et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method
AV Rudnev et al.
JOURNAL OF SEPARATION SCIENCE (2005)
Advances in analytical methodology for bioinorganic speciation analysis: metallomics, metalloproteomics and heteroatom-tagged proteomics and metabolomics
J Szpunar
ANALYST (2005)
Intact human holo-transf errin interaction with oxaliplatin
YY Zhao et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Interactions of platinuim(II) complexes with sulfur-containing peptides studied by electrospray ionization mass spectrometry and tandem mass spectrometry
R Miao et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC-ICP-MS
S Hann et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2005)
Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex
E Jerremalm et al.
PHARMACEUTICAL RESEARCH (2004)
The expanding role of systemic therapy in head and neck cancer
EEW Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Inductively coupled plasma mass spectrometry and electrospray mass spectrometry for speciation analysis: applications and instrumentation
AL Rosen et al.
SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY (2004)
Evaluation of arsenic species-protein binding in cardiovascular tissues by bidimensional. chromatography with ICP-MS detection
I Pizarro et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2004)
Kinetic study on the reactions of platinum drugs with glutathione
D Hagrman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Protein interactions with platinum-DNA adducts: from structure to function
SG Chaney et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Ultratrace voltammetric determination of DNA-bound platinum in patients after administration of oxaliplatin
G Weber et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2004)
Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: Characterization of interactions between Pt(II) complexes and human serum albumin
AR Timerbaev et al.
ELECTROPHORESIS (2004)
Metallomics as integrated biometal science
H Haraguchi
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2004)
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS)
A Ghezzi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Metallomics: a new frontier in analytical chemistry
J Szpunar
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2004)
Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group
R Mandal et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Gallium in cancer treatment
MA Jakupec et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Separation of cisplatin and its hydrolysis products using electrospray ionization high-field asymmetric waveform ion mobility spectrometry coupled with ion trap mass spectrometry
M Cui et al.
ANALYTICAL CHEMISTRY (2003)
Direct evidence for co-binding of cisplatin and cadmium to a native zinc- and cadmium-containing metallothionein
R Mandal et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2003)
Kinetic study on the reaction of cisplatin with metallothionein
D Hagrman et al.
DRUG METABOLISM AND DISPOSITION (2003)
Mass spectrometric studies of cisplatin-induced changes of hemoglobin
R Mandal et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2003)
Electrospray ionization mass spectrometry coupled to liquid chromatography for detection of cisplatin and its hydrated complexes
M Cui et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2003)
Studies of cisplatin and hemoglobin interactions using nanospray mass spectrometry and liquid chromatography with inductively-coupled plasma mass spectrometry
R Mandal et al.
ANALYST (2003)
Kinetic study of the reaction of cisplatin with thiols
JC Dabrowiak et al.
DRUG METABOLISM AND DISPOSITION (2002)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interactions of antitumoral platinum-group metallodrugs with albumin
BP Espósito et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Multidimensional approaches in biochemical speciation analysis
J Szpunar et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2002)
Simultaneous determination of intact cisplatin and its metabolite monohydrated cisplatin in human plasma
M Verschraagen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs
BAJ Jansen et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
Capillary electrophoresis of platinum-group elements analytical, speciation and biochemical studies
AR Timerbaev et al.
JOURNAL OF CHROMATOGRAPHY A (2002)
Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs
PD Sadowitz et al.
DRUG METABOLISM AND DISPOSITION (2002)
Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: the interaction of cisplatin with transferrin
CS Allardyce et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2002)
Anti-tumour platinum acylthiourea complexes and their interactions with DNA
A Rodger et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2002)
Inductively coupled plasma mass spectrometry to identify protein drug targets from whole cell systems
CS Allardyce et al.
CHEMICAL COMMUNICATIONS (2001)
2.4 Å crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex
B Spingler et al.
INORGANIC CHEMISTRY (2001)
HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate
S Hann et al.
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY (2001)
Rabbit liver metallothionein subisoform characterisation using liquid chromatography hyphenated to diode array detection and electrospray ionisation mass spectrometry
G van Vyncht et al.
CHROMATOGRAPHIA (2000)
Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines
J Holford et al.
EUROPEAN JOURNAL OF CANCER (2000)
Guidelines for terms related to chemical speciation and fractionation of elements. Definitions, structural aspects, and methodological approaches (IUPAC Recommendations 2000)
DM Templeton et al.
PURE AND APPLIED CHEMISTRY (2000)
分享论文
